- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05277194
Reducing Challenging Behaviors in Children With Autism Through Digital Health
July 22, 2025 updated by: University of Pennsylvania
Investigating the Impact of an Emotional Stress Alarm App (KeepCalm) on Managing Stress and Preventing Challenging Behaviors in Children With Autism
School-based behavioral approaches to managing challenging behaviors in children with ASD are limited by three key factors: 1) children with ASD often have difficulties communicating their emotions; 2) it is challenging to implement evidence-based, personalized strategies for individual children, and; 3) it is difficult for teachers to track which strategies are successful for individual children.
The investigators' personalized mobile-health emotion regulation application (m-health app) will pair heart rate tracking with digital tools to help reduce challenging behavior by supporting stress detection, reminding teachers of specific behavioral strategies and helping teachers to track progress.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The project will develop and pilot test a personalized medicine mobile health emotion regulation application (the m-health KeepCalm app) that incorporates physiological stress measurement to support evidence-based practices for reducing challenging behavior in children with autism spectrum disorder (ASD).
As much as 80% of children with ASD exhibit challenging behaviors that can have a devastating impact on personal and family well-being, contribute to teacher burnout and require frequent hospitalization.
Evidence-based practices for reducing these behaviors emphasize uncovering triggers, yet parents and teachers often report that challenging behaviors surface without warning.
Challenging behaviors caused by emotion dysregulation can be the most difficult to predict, as children with ASD often have difficulty communicating their distress before it results in challenging behavior.
Exciting recent advances in digital technology now allow measurement of momentary emotion dysregulation, using physiological indices.
The investigators' pilot data from four separate samples demonstrate that increased heart rate predicts onset of challenging behavior in children with ASD.
In order to tailor the m-health KeepCalm app to end users and avoid potential barriers to its adoption, in Aim 1, the investigators will evaluate the acceptability, feasibility, and appropriateness of app, and the needs of educational teams in managing stress in children with ASD and challenging behaviors, by conducting interviews with teachers of children with ASD, parents of children with ASD and school administrators, and conducting structured in-class observations with teachers.
Through the activities of Aim 2, the researchers will improve the m-health KeepCalm app, building on their initial app prototype, in collaboration with their established research partner, the Translational Informatics Unit, Children's Hospital of Philadelphia, and their established community partner, the School District of Philadelphia.
The investigators will do this through 1) exploratory work on the specificity of heart rate increase to challenging behavior, on app clinical decision support timing, and on the association of app false positives and negatives to movement or child factors; 2) monthly advisory board meetings with expert stakeholders for app development guidance, and; 3) rapid-cycle prototyping of the app with 10 educational teams (i.e.
1-2 children with ASD, and their teacher and classroom aide, if they have one).
This will allow for iterative improvement based on each user's experience.
Through Aim 3, the researchers will test the app for usability, acceptability, feasibility and appropriateness, as well as preliminary effectiveness with 30 educational teams in a randomized waitlist field trial over a 3-month period.
Successful completion of these aims will result in a novel m-health app designed to help teachers support emotion regulation, and reduce or prevent challenging behavior in children with ASD, using evidence-based strategies.
These activities will lay the foundation for an R01 to evaluate the effectiveness of the m-health KeepCalm app in a full- scale randomized field trial.
This proposal aligns with the strategic plan of the Interagency Autism Coordinating Committee, to maximize the potential for technology-based interventions to improve the lives of people with ASD.
Study Type
Interventional
Enrollment (Actual)
87
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19146
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
3 years to 12 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Preschool or elementary school child with autism along with a parent and teacher and/or classroom aide
- Child must have challenging behaviors including but not limited to aggression, escape behavior, loud noises, non-compliance, property destruction, rigid/inflexible behavior, self-injury, and transition difficulties
- Adult participants must have access to an iPhone in order to test the app or be willing to use a provided study iPhone
Exclusion Criteria:
- Child does not exhibit challenging behaviors
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: KeepCalm App
The KeepCalm app is designed to help manage stress and prevent challenging behaviors in children with autism.
The app uses physiological stress tracking, assessed using heart rate monitoring, to indicate when challenging behaviors are likely to occur.
The app then recommends strategies to help prevent the onset of challenging behaviors.
The app can also be used to track trends in triggers, behaviors, and strategies, and to communicate this information to parents and other members of a child's educational team.
|
The KeepCalm app is designed to help manage stress and prevent challenging behaviors in children with autism.
|
|
No Intervention: Waitlist Control
Individuals assigned to the waitlist control condition will gain access to the KeepCalm app following the study's completion.
During the trial, they will not receive any intervention, but will complete baseline and post-intervention measures during the trial.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
System Usability Scale (SUS)
Time Frame: 3 months post-baseline
|
The System Usability Scale (SUS) measures perceptions of usability of a given system, in this case, the KeepCalm app.
The scale consists of 10 items, each rated on a 5-point Likert Scale from 1 ("Strongly disagree") to 5 ("Strongly agree").
Responses are transformed to get a total range of possible values from 0-100, with higher scores indicating higher perceptions of usability.
Typically, a score above 68 is regarded as a good score.
|
3 months post-baseline
|
|
Acceptability of Intervention Measure (AIM)
Time Frame: 3 months post-baseline
|
The Acceptability of Intervention Measure (AIM) is used to measure the acceptability of an intervention.
The scale consists of 4 items rated on a 5-point Likert Scale from 1 ("Completely disagree") to 5 ("Completely agree").
The score consists of the sum of the items, ranging from 5 to 20, with higher scores indicating greater acceptability of the intervention.
|
3 months post-baseline
|
|
Feasibility of Intervention Measure (FIM)
Time Frame: 3 months post-baseline
|
The Feasibility of Intervention Measure (FIM) is used to measure the feasibility of an intervention.
The scale consists of 4 items rated on a 5-point Likert Scale from 1 ("Completely disagree") to 5 ("Completely agree").
The score consists of the sum of the items, ranging from 5 to 20, with higher scores indicating greater feasibility of the intervention.
|
3 months post-baseline
|
|
Intervention Appropriateness Measure (IAM)
Time Frame: 3 months post-baseline
|
The Intervention Appropriateness Measure (IAM) is used to measure the appropriateness of an intervention.
The scale consists of 4 items rated on a 5-point Likert Scale from 1 ("Completely disagree") to 5 ("Completely agree").
The score consists of the sum of the items, ranging from 5 to 20, with higher scores indicating greater appropriateness of the intervention.
|
3 months post-baseline
|
|
Qualitative interview
Time Frame: 3 months post-baseline
|
This interview will assess the intervention's usability, appropriateness, feasibility, and acceptability in a qualitative interview format.
|
3 months post-baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
School Situations Questionnaire (SSQ)
Time Frame: baseline and 3 months post-baseline
|
The School Situations Questionnaire (SSQ) assessing challenging behaviors within the context of school.
The scale assesses both the presence and the severity of challenging behaviors by asking the teacher whether or not a given behavior occurs for that child and to rate the severity.
The scale yields two summary scores.
The first is the number of problems score which is a sum of the number of problems endorsed, ranging from 0-8 with higher scores indicating greater problems endorsed.
The second is the mean severity, calculated as the mean severity for the items endorsed, ranging from 1 to 9 with higher numbers indicating more severe problems.
|
baseline and 3 months post-baseline
|
|
Institute for Basic Research Modified Overt Aggression Scale (IBR-MOAS)
Time Frame: baseline and 3 months post-baseline
|
The Institute for Basic Research Modified Overt Aggression Scale (IBR-MOAS) measures the frequency and severity of aggressive behavior episodes.
The scale is divided into four components: verbal aggression, aggression against property, autoaggression, and physical aggression.
There are 4 items in each category, scored from 0-4 (with higher numbers indicating greater severity) and raters can select as many items as are relevant in the category.
The items are then summed within each category to create a summed category score, and then each category is multiplied by its specified weight to give a total weighted aggression score, ranging from 0 to 100, with higher scores indicating greater problems with aggression.
|
baseline and 3 months post-baseline
|
|
Emotion Dysregulation Inventory (EDI)
Time Frame: baseline and 3 months post-baseline
|
The Emotion Dysregulation Inventory (EDI) measures emotion dysregulation by asking raters to identify how much of a problem certain emotions and behaviors are for the person being rated.
The scale consists of 66 items that are rated for how much of a problem the behavior has been in the last 7 days ("not at all", "mild", "moderate", "severe", "very severe").
This ratings are converted into a numerical rating from 0 ("not at all") to 4 ("very severe"), and then summed to create a total score ranging from 0-264, which higher scores indicating greater emotion dysregulation.
|
baseline and 3 months post-baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Artifact removal
Time Frame: through study participation, an average of 3 months
|
Number of artifacts detected during the testing period
|
through study participation, an average of 3 months
|
|
Offline mode activations
Time Frame: through study participation, an average of 3 months
|
Proportion of time offline mode is activated over the testing week based on accelerometry data threshold
|
through study participation, an average of 3 months
|
|
Clinical decision support success
Time Frame: through study participation, an average of 3 months
|
Proportion of alarms/emotion regulation strategy app push notifications that result in timely strategy implementation, as measured during the observation session
|
through study participation, an average of 3 months
|
|
False positives/negatives
Time Frame: through study participation, an average of 3 months
|
Proportion of alarms that appear not to be associated with an oncoming challenging behavior (e.g.
due to child movement)/challenging behaviors that occurred without an alarm, measured during the observation session
|
through study participation, an average of 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 26, 2023
Primary Completion (Actual)
June 30, 2025
Study Completion (Actual)
June 30, 2025
Study Registration Dates
First Submitted
February 4, 2022
First Submitted That Met QC Criteria
March 10, 2022
First Posted (Actual)
March 14, 2022
Study Record Updates
Last Update Posted (Actual)
July 25, 2025
Last Update Submitted That Met QC Criteria
July 22, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 829690
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.